Home › Funds › AMF Tjanstepension AB › ELV

AMF Tjanstepension AB position in ELV

ELEVANCE HEALTH INC FORMERLY · Health Care

AMF Tjanstepension AB reported holding 238,133 shares of ELV (ELEVANCE HEALTH INC FORMERLY) in its Q3 2026 13F filing — a position valued at US$92.6M, representing 0.54% of its reported portfolio and ranking #42 among its reported holdings. AMF Tjanstepension AB has disclosed ELV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)238.13K sh
Reported value held$92.59M
Portfolio Weight0.54%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How AMF Tjanstepension AB's ELV position evolved

AMF Tjanstepension AB first disclosed a stake in ELV in Q3 2023 at 94,141 shares (US$41.0M). The position peaked in Q3 2026 at 238,133 shares, worth US$92.6M. Across 13 filings, AMF Tjanstepension AB increased the stake 5 time(s), trimmed it 3 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 238,133 shares valued at US$92.6M. Notable position changes include a 123% increase in Q4 2024 (shares rose 18% over the following quarter), a 44% increase in Q2 2025 (shares fell 16% over the following quarter), a 55% increase in Q3 2025 (shares rose 9% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 94.14K $41.00M New
Q4 2023 117.24K $55.30M Add
Q1 2024 75.58K $39.20M Reduce
Q2 2024 47.25K $25.61M Reduce
Q3 2024 47.25K $24.58M Hold
Q4 2024 105.33K $38.87M Add
Q1 2025 103.79K $45.16M Reduce
Q2 2025 149.52K $58.18M Add
Q3 2025 231.56K $74.82M Add
Q4 2025 231.44K $81.13M Hold
Q1 2026 238.13K $69.71M Add
Q2 2026 238.13K $92.09M Hold
Q3 2026 238.13K $92.59M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ELV and 13F data

ELV (ELEVANCE HEALTH INC FORMERLY) is a Health Care company. 23 other funds we track also report a position in ELV — the largest reported positions include Wellington Management Group (US$3.56B), WELLINGTON MANAGEMENT GROUP LLP (US$3.56B), Sanders Capital, LLC (US$2.27B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ELV

All ELV fund holders →

FAQ

How long has AMF Tjanstepension AB held ELV?

AMF Tjanstepension AB has disclosed ELV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is AMF Tjanstepension AB's current position in ELV?

As of Q3 2026, AMF Tjanstepension AB holds 238.13K shares of ELV (ELEVANCE HEALTH INC FORMERLY), valued at $92.59M, representing 0.54% of its reported portfolio and ranking #42.

Has AMF Tjanstepension AB been buying or selling ELV?

In the latest 13F filing (Q3 2026), AMF Tjanstepension AB held unchanged its position in ELV. The position peaked in Q3 2026 at 238.13K shares.

Which other funds hold ELV?

Other major institutional holders of ELV include Wellington Management Group, WELLINGTON MANAGEMENT GROUP LLP, Sanders Capital, LLC, among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.